OBJECTIVE: We aimed to establish the prevalence of human immunodeficiency virus (HIV)-associated malignancies in children attending a care and treatment clinic at Kilimanjaro Christian Medical Centre. MATERIALS AND METHODS: This was a retrospective cross-sectional hospital-based study of children who attended an HIV care and treatment clinic between 2006 and 2014. Children 2 months to 17 years of age were eligible for participation. The data on social demographic and clinical characteristics were extracted from the medical record. A multivariate logistic regression model was developed to determine predictors of HIV-associated malignancies. RESULTS: Medical records from 721 HIV-infected children were reviewed. The median age (interquartile range) at HIV diagnosis was 5.7 (2.0 to 9.4) years. Among them, 34 (4.7%) had HIV-associated malignancies. The most common (n=24, 70.3%) malignancy was the Kaposi sarcoma. Age at HIV diagnosis was significantly associated with HIV-associated malignancies (adjusted odds ratio, 1.2; 95% confidence interval, 1.0-1.3). Among 34 patients with HIV-associated malignancies, 11 (32.4%) died. Seven (20.6%) patients reported complete remission from their malignancies, and outcomes for 6 patients were unknown. CONCLUSIONS: The prevalence of HIV-associated malignancies was high and was associated with late HIV diagnosis. The Kaposi sarcoma was the commonest malignancy. Early HIV diagnosis and treatment in children might reduce HIV-associated malignancies.
OBJECTIVE: We aimed to establish the prevalence of human immunodeficiency virus (HIV)-associated malignancies in children attending a care and treatment clinic at Kilimanjaro Christian Medical Centre. MATERIALS AND METHODS: This was a retrospective cross-sectional hospital-based study of children who attended an HIV care and treatment clinic between 2006 and 2014. Children 2 months to 17 years of age were eligible for participation. The data on social demographic and clinical characteristics were extracted from the medical record. A multivariate logistic regression model was developed to determine predictors of HIV-associated malignancies. RESULTS: Medical records from 721 HIV-infected children were reviewed. The median age (interquartile range) at HIV diagnosis was 5.7 (2.0 to 9.4) years. Among them, 34 (4.7%) had HIV-associated malignancies. The most common (n=24, 70.3%) malignancy was the Kaposi sarcoma. Age at HIV diagnosis was significantly associated with HIV-associated malignancies (adjusted odds ratio, 1.2; 95% confidence interval, 1.0-1.3). Among 34 patients with HIV-associated malignancies, 11 (32.4%) died. Seven (20.6%) patients reported complete remission from their malignancies, and outcomes for 6 patients were unknown. CONCLUSIONS: The prevalence of HIV-associated malignancies was high and was associated with late HIV diagnosis. The Kaposi sarcoma was the commonest malignancy. Early HIV diagnosis and treatment in children might reduce HIV-associated malignancies.
Authors: Alan Davidson; Rosalinda D Wainwright; David K Stones; Mariana Kruger; Marc Hendricks; Jennifer Geel; Janet Poole; David Reynders; Fareed Omar; Rema Mathew; D Cristina Stefan Journal: J Pediatr Hematol Oncol Date: 2014-03 Impact factor: 1.289
Authors: Elena Chiappini; Elettra Berti; Ketty Gianesin; Maria Raffaella Petrara; Luisa Galli; Carlo Giaquinto; Maurizio de Martino; Anita De Rossi Journal: Cancer Lett Date: 2014-02-07 Impact factor: 8.679
Authors: Kristin Schroeder; Anthony Saxton; Jessica McDade; Christina Chao; Nestory Masalu; Colin Chao; Daniel S Wechsler; Beda Likonda; Nelson Chao Journal: J Glob Oncol Date: 2017-06-09
Authors: Salum J Lidenge; For Yue Tso; Yasaman Mortazavi; John R Ngowi; Danielle M Shea; Julius Mwaiselage; Charles Wood; John T West Journal: Cancers (Basel) Date: 2020-06-16 Impact factor: 6.639